Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,546
Recruiting: 1,932
Ph III recruiting: 225
Growth YoY: +16.4%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 251–300 of 15,539 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06529822	Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease	recruiting	Phase 1	64	Washington University School of MedicineOTHER	1	Sep 21, 2026	clinicaltrials
NCT06594887	Rectal Spacers Use in Prostate Cancer Radiation Therapy	active not recruiting	N/A	50	Princeton ProCure management, LLC.OTHER	1	Sep 21, 2026	clinicaltrials